Genmab
GMAB
#721
Rank
$23.87 B
Marketcap
$36.56
Share price
1.67%
Change (1 day)
1.90%
Change (1 year)

Market capitalization of Genmab (GMAB)

Market cap: $23.87 Billion

As of March 2023 Genmab has a market cap of $23.87 Billion. This makes Genmab the world's 721th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Genmab from 2010 to 2023

End of year Market Cap

Year Market cap Change
2023$23.87 B-14.59%
2022$27.95 B6.75%
2021$26.18 B-1.86%
2020$26.68 B85.08%
2019$14.41 B43.77%
2018$10.02 B-0.52%
2017$10.08 B0.47%
2016$10.03 B25.41%
2015$8.00 B138.74%
2014$3.35 B65.01%
2013$2.03 B192.75%
2012$0.69 B136.2%
2011$0.29 B-51.56%
2010$0.60 B

End of Day market cap according to different sources

On Mar 20th, 2023 the market cap of Genmab was reported to be:

$23.48 Billion
by Yahoo Finance
$23.48 Billion
by CompaniesMarketCap
$23.71 Billion
by Nasdaq
$23.68 Billion
by Iex Cloud